Taking TRIPS to India - Novartis, patent law, and access to medicines

New England Journal of Medicine

Volumn 356, Issue 6, 2007, Pages 541-543

  Mueller, Janice M ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMATINIB; PEGINTERFERON ALPHA2A;

CHEMICAL COMPOSITION; CHRONIC MYELOID LEUKEMIA; DRUG INDUSTRY; DRUG MANUFACTURE; FOOD AND DRUG ADMINISTRATION; HEALTH CARE ORGANIZATION; HEALTH INSURANCE; HEALTH PROGRAM; HEPATITIS C; HUMAN; MEDICINE; PATIENT ADVOCACY; PRIORITY JOURNAL; PUBLIC HEALTH; SHORT SURVEY;

EID: 33846884617     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMp068245     Document Type: Article

References (5)

1. Novartis challenges the Indian patent law. Zurich, Switzerland: Berne Declaration, October 9, 2006. (Accessed January 18, 2007, at http://www.evb.ch/en/p25011414.html.)
2. NGOs attack Novartis over drug access. Geneva, Switzerland: Swissinfo/Swiss Radio International (SRI), October 12, 2006. (Accessed January 18, 2007, at http://www.swissinfo.org/eng/In_depth/detail/ NGOs_attack_Novartis_over_drug_access.html?siteSect=107&sid= 7159190&cKey=1160714785000.)
3. As Novartis challenges India's patent law, MSF warns access to medicines is under threat. Press release of Médicins sans Frontières, September 26, 2006. (Accessed January 18, 2007, at http://www. doctorswithoutborders.org/pr/2006/09-26-2006_1.cfm.)
4. Bhargava A, Srinivasan S. Price regulation of essential medicines. The Hindu. October 17, 2006. (Accessed January 18, 2007, at http://www.thehindu.com/ 2006/10/17/stories/2006101702601000.htm.)
5. Novartis: writ petition against denial of Gleevec patient. Affidavit filed on behalf of the petitioner: Novartis AG v. Union of India et al., W.P. No. 24754 of 2006 (Mad. High Ct.) (May 19, 2006). (Accessed January 18, 2007, at http://www.lawyerscollective.org/.)